Open AccessRole of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma: CEA Level Before Operation is a Significant Prognostic Indicator in Patients With Locally Advanced Pancreatic Cancer Treated With Neoadjuvant Therapy Followed by Surgical Resection
Author(s) -
Hiroyuki Kato,
Masashi Kishiwada,
Aoi Hayasaki,
Jackson Chipaila,
Koki Maeda,
Daisuke Noguchi,
Kazuyuki Gyoten,
Takehiro Fujii,
Yusuke Iizawa,
Akihiro Tanemura,
Yasuhiro Murata,
Naohisa Kuriyama,
Masanobu Usui,
Hiroyuki Sakurai,
Shuji Isaji,
Shugo Mizuno
Publication year - 2020
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/sla.0000000000004148
Subject(s) - medicine , carcinoembryonic antigen , adenocarcinoma , oncology , ca19 9 , pancreatic cancer , neoadjuvant therapy , cancer , carcinoma , gastroenterology , breast cancer
The aim of the study was to identify the prognostic factors before neoadjuvant chemoradiotherapy (NCRT) in the patients with localized PDAC. Furthermore, to identify the post-surgical survival predictors of patients with LAPC.